Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
- PMID: 15987397
- PMCID: PMC1175886
- DOI: 10.1186/cc3512
Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
Abstract
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) causes severe morbidity and mortality in intensive care units (ICUs) worldwide. The purpose of this study was to determine whether intranasal mupirocin prophylaxis is useful to prevent ICU-acquired infections with MRSA.
Materials and methods: We conducted a 4-year observational retrospective study in a 15-bed adult medical ICU. During the first 2-year period mupirocin ointment was included in the MRSA control programme; during the second, mupirocin was not used. The main endpoint was the number of endogenous ICU-acquired infections with MRSA.
Results: The number of endogenous acquired infections was significantly higher during the second period than during the first (11 versus 1; P = 0.02), although there was no significant difference in the total number of patients infected with MRSA between the two periods. We also observed that nasal MRSA decolonisation was significantly higher in the mupirocin period than in mupirocin-free period (P = 0.002).
Conclusion: Our findings suggest that intranasal mupirocin can prevent endogenous acquired MRSA infection in an ICU. Further double-blind, randomised, placebo-controlled studies are needed to demonstrate its cost-effectiveness and its impact on resistance.
Comment in
-
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?Crit Care. 2005 Jun;9(3):257-8. doi: 10.1186/cc3720. Epub 2005 May 5. Crit Care. 2005. PMID: 15987417 Free PMC article.
References
-
- Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy CJ, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus : roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis. 1997;25:647–653. - PubMed
-
- Albertini MT, Benoit C, Berardi L, Berrouane Y, Boisivon A, Cahen P, Cattoen C, Costa Y, Darchis P, Deliere E, et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect. 2002;52:107–113. doi: 10.1053/jhin.2002.1286. - DOI - PubMed
-
- Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1998;27:543–550. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
